Skip to main content

Table 7 Overall survival of the leukemic patients and its relation to different prognostic factors

From: Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients

  Cumulative survival at 24 month (%) Median Survival (months) p value
Diagnosis
 ALL 47.4 23.5 0.518
 AML 33.3 15.6  
DFN (days)
 <26.5 57.9 32.2  
 >26.5 35.4 16.5 0.024
ANC (×109/L)
 <0.13 15.6 16.5  
 ≥0.13 56.6 32.3 0.044
Plt count (×109/L)
 <39.5 14.7 16.5  
 ≥39.5 68.3 44.3 0.024
ALC (×109/L)
 <1.2 12.2 16.5 0.042
 ≥1.2 62.6 32.3  
CMV score
 <7 (n = 8) 80.0 15.1 0.002
 ≥7 (n = 20) 26.1% 23.5  
EBV PCR Serum
 Positive (n = 9) 68.6 91.6  
 Negative (n = 29) 33.7 21.5 0.038
CMV&EBV in serum
 Both negative(n = 15) 30.8 21.6 0.079
 CMV alone/EBV alone(n = 15) 25.9 32.3
 Both positive(n = 8) 62.5 91.6
  1. Numerical factors were divided according to their median values
  2. DFN Duration of febrile neutropenia, Plt platelets, ANC Absolute neutrophilic count, ALC Absolute lymphocytic count